News & Events

Perspectives in FTD Research Webinar: Gene Therapy for FTD — What Do I Need to Know?

In the last several years, new clinical trials have begun for drugs that can potentially slow or stop the progression of FTD caused by specific genes. Gene therapy and gene…

MORE

News Report on Tallahassee Couple’s FTD Journey Highlights Challenges of Misdiagnosis

A report aired by Tallahassee news station WTXL27 shares how FTD has affected the lives of a local couple. Larry Davis told reporter Maya Sargent that his FTD diagnosis and…

MORE

Volunteer Update: AFTD Ambassadors Welcome New Cohort

The AFTD Ambassador program was launched in 2019 as a new opportunity for AFTD’s volunteer leadership. Since then, the initial cohort of Ambassadors has grown into an enthusiastic, highly motivated…

MORE

Public Benefits When Notable Names Share Neurological Challenges, UCLA Professor Writes

In an opinion piece published last month in the Los Angeles Times, Keith Vossel, MD, of the University of California, Los Angeles, writes that celebrities and politicians who share their…

MORE

January 18 — Starting Fresh 2024: Empowering Caregivers Conference

AFTD is co-sponsoring Starting Fresh 2024: Empowering Caregivers, a caregivers conference held by the Alzheimer’s Association Capital of Texas Chapter at the Georgetown Public Library on January 18 from 9:00…

MORE

Advancing Hope: AFTD Holds 2023 Holloway Summit Meeting on Biomarkers for FTD

The second annual AFTD Holloway Summit, focused on biomarkers for FTD, was held from November 30 to December 1 in Miami Beach, FL. More than 50 attendees from academia, industry,…

MORE

Dear HelpLine: Dealing With Genetic Uncertainty

Dear HelpLine, Each time I visit home for the holidays and see firsthand how FTD has affected my parent, my anxiety increases. Is it normal to worry that other family…

MORE

AFTD and ADDF Extend Treat FTD Fund Program Through 2035

AFTD and the Alzheimer’s Drug Discovery Foundation (ADDF) have committed to extending the Treat FTD Fund program through 2035, providing an additional ten years of support to accelerate treatment development…

MORE